We are live on
!
Find out more
Zevra Therapeutics
ZVRA
ZVRA
38 hedge funds and large institutions have $14.6M invested in Zevra Therapeutics in 2019 Q1 according to their latest regulatory filings, with 6 funds opening new positions, 10 increasing their positions, 8 reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
25% more repeat investments, than reductions
Existing positions increased: 10 | Existing positions reduced: 8
0% more funds holding
Funds holding: 38 → 38 (0)
0% more first-time investments, than exits
New positions opened: 6 | Existing positions closed: 6
11% less capital invested
Capital invested by funds: $16.5M → $14.6M (-$1.86M)
55% less call options, than puts
Call options by funds: $29K | Put options by funds: $64K
Holders
38
Holders Change
–
Holders Change %
0%
% of All Funds
0.82%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
6
Increased
10
Reduced
8
Closed
6
Calls
$29K
Puts
$64K
Net Calls
-$35K
Net Calls Change
-$33K
Top Buyers
Top Sellers
| 1 |
Alyeska Investment Group
Chicago,
Illinois
|
-$741K |
| 2 |
Victory Capital Management
San Antonio,
Texas
|
-$459K |
| 3 |
CI
Cowen Inc
New York
|
-$294K |
| 4 |
JGC
J. Goldman & Co
New York
|
-$160K |
| 5 |
AWA
Arete Wealth Advisors
Chicago,
Illinois
|
-$97.1K |
